Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease.

Mattisson IY, Björkbacka H, Wigren M, Edsfeldt A, Melander O, Fredrikson GN, Bengtsson E, Gonçalves I, Orho-Melander M, Engström G, Almgren P, Nilsson J

EBioMedicine 26 (-) 187-197 [2017-12-00; online 2017-11-24]

Affinity Proteomics Stockholm [Service]

Clinical Biomarkers [Service]

PubMed 29208468

DOI 10.1016/j.ebiom.2017.11.023

Crossref 10.1016/j.ebiom.2017.11.023

pii: S2352-3964(17)30466-8
pmc: PMC5836474


Publications 8.1.0